medigraphic.com
ISSN 0301-696X (Print)
Órgano de difusión del Servicio de Sanidad Militar y del Colegio Nacional de Médicos Militares

2017, Number 5

<< Back Next >>

Rev Sanid Milit Mex 2017; 71 (5)

Is it possible to predict and prevent preeclampsia today?

Rodríguez BR, Neri RE

Language: Spanish
References: 11
Page: 437-442
PDF size: 168.04 Kb.


ABSTRACT

Hypertensive disorders are among the most common medical complications of pregnancy; the reported incidence is between five and 10% and they are a major cause of maternal, fetal, and neonatal morbidity and mortality worldwide. They occur only during pregnancy, and they are, by definition, precursors of a potentially severe disease (eclampsia). Their treatment has remained the same for hundreds of years: delivery. Their fundamental cause and prevention continue to elude researchers. We review the prediction and prevention of preeclampsia.


REFERENCES

  1. Sibai MB. Preeclampsia and hypertensive disorders. In: Landon M, Gabbe S, Niebyl J, Simpson J, Galan H, Jauniaux E, eds. Obstetrics, normal and problem pregnancies. 7th edition. Elsevier; 2017. pp. 668-670.

  2. Sibai BM. First-trimester screening with combined maternal clinical factors, biophysical and biomarkers to predict preterm pre-eclampsia and hypertensive disorders: are they ready for clinical use? BJOG. 2015; 122 (3): 282-283.

  3. Pauli JM, Repke JT. Preeclampsia: short-term and long-term implications. Obstet Gynecol Clin North Am. 2015; 42 (2): 299-313.

  4. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol. 2008; 112 (2 Pt 1): 359-372.

  5. Wu P, van den Berg C, Alfirevic Z, O’Brien S, Röthlisberger M, Baker PN et al. Early pregnancy biomarkers in pre-eclampsia: a systematic review and meta-analysis. Int J Mol Sci. 2015; 16 (9): 23035-23056.

  6. Poon LC, Nicolaides KH. First-trimester maternal factors and biomarker screening for preeclampsia. Prenat Diagn. 2014; 34 (7): 618-627.

  7. Gigučre Y, Massé J, Thériault S, Bujold E, Lafond J, Rousseau F et al. Screening for pre-eclampsia early in pregnancy: performance of a multivariable model combining clinical characteristics and biochemical markers. BJOG. 2015; 122 (3): 402-410.

  8. Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 2012; 125 (7): 911-919.

  9. Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M et al. Soluble fms-like tyrosine kinase-1-to-placental growth factor ratio and time to delivery in women with suspected preeclampsia. Obstet Gynecol. 2016; 128 (2): 261-269.

  10. Myatt L, Clifton RG, Roberts JM, Spong CY, Hauth JC, Varner MW et al. The utility of uterine artery Doppler velocimetry in prediction of preeclampsia in a low-risk population. Obstet Gynecol. 2012; 120 (4): 815-822.

  11. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013; 122 (5): 1122-1131.




2020     |     www.medigraphic.com